Tirofiban is superior to aspirin in non-obstructive strokes

Published Date: 08 Mar 2023

Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.

Read Full News

Latest News

Catheter Fibrinolysis Cuts Early Risk in Pulmonary Embolism

Ultrasound-facilitated catheter-directed fibrinolysis plus anticoagulation vs anticoagulation alone reduces clinical deterioration in patients with acute intermediate-risk pulmonary embolism.

Tape Strips Detect Immune Markers in Orphan Ichthyoses

Tape-strip RNA sequencing identifies shared Th17/Th22 upregulation and epidermal differentiation complex activation across four orphan ichthyoses, pilot study shows.

Dendritic Cell Strategies May Reduce Cancer Recurrence Risk

Dendritic cells within tumors may enable personalized immunotherapy strategies that reduce the risk for cancer relapses by strengthening immune memory.

Sunflower Seed Sensitization Outpaces True Allergy in Kids

More than 80% of children sensitized to sunflower seeds and advised to avoid them can tolerate the seeds during an oral food challenge.

Adding Steroid Shows No Heart Benefit in Kawasaki Disease

Adding prednisolone to the standard treatment for Kawasaki disease in children does not lower the incidence of coronary artery lesions at 1 month after illness onset, according to a phase 3 trial.

Torque Teno Virus Predicts Malignancy Post-Kidney Transplant

Higher torque teno virus loads during the first year after kidney transplant are associated with an increased risk for malignancies in subsequent years, a prospective study finds.

Todays Updates

Where Does Mistletoe Extract Fit in Supportive Cancer Care?

Mistletoe therapy may improve the QOL of patients with cancer; however, evidence does not support a survival benefit, limiting its role in routine oncology care.

A Chemo-Free Option for Some Advanced Endometrial Cancers?

A phase 2 study suggests that immunotherapy plus radiation could spare some patients with advanced endometrial cancer from chemotherapy.

Todays Updates

Where Does Mistletoe Extract Fit in Supportive Cancer Care?

Mistletoe therapy may improve the QOL of patients with cancer; however, evidence does not support a survival benefit, limiting its role in routine oncology care.

A Chemo-Free Option for Some Advanced Endometrial Cancers?

A phase 2 study suggests that immunotherapy plus radiation could spare some patients with advanced endometrial cancer from chemotherapy.

Latest News

Ultrasound-facilitated catheter-directed fibrinolysis plus anticoagulation vs anticoagulation alone reduces clinical deterioration in patients with acute intermediate-risk pulmonary embolism.

Tape-strip RNA sequencing identifies shared Th17/Th22 upregulation and epidermal differentiation complex activation across four orphan ichthyoses, pilot study shows.

Dendritic cells within tumors may enable personalized immunotherapy strategies that reduce the risk for cancer relapses by strengthening immune memory.

More than 80% of children sensitized to sunflower seeds and advised to avoid them can tolerate the seeds during an oral food challenge.

Adding prednisolone to the standard treatment for Kawasaki disease in children does not lower the incidence of coronary artery lesions at 1 month after illness onset, according to a phase 3 trial.

Higher torque teno virus loads during the first year after kidney transplant are associated with an increased risk for malignancies in subsequent years, a prospective study finds.

News All Time

New Pulmonary Embolism Clinical Categories PCPs Should Know

Dr Nina Lum discusses key takeaways of new PE clinical categories for primary care physicians and providers.

Amgen's Lung Cancer Drug Tarlatamab Wins China Approval

Amgen's lung cancer drug tarlatamab has won ⁠approval from China's National Medical Products Administration.

US FDA Expands Approval for Travere's Drug for Rare Kidney Disease

The U.S. Food and Drug Administration has approved the expanded use of Travere Therapeutics' ⁠drug to treat a rare kidney disorder, the company said on Monday.

EPP and XLP: Dersimelagon Delays Photodermatoses Prodrome

A dermatologist with erythropoietic protoporphyria herself presents results of the INSPIRE randomized controlled trial of dersimelagon.

Preparing for the Next Pandemic: What the EU Wants

The EU aims to offer pharmaceutical companies ‘workable terms’ in policies designed to improve future pandemic response.

Gastritis Study Reveals Antibody-Anemia Connection

Anemia is common in patients with autoimmune gastritis and is associated with positivity for anti-intrinsic factor antibodies.

Pemphigus: Rituximab Shows Lower Cancer Risk Than Other Txs

Rituximab is linked to a lower 5-year risk for new cancer than mycophenolate mofetil or azathioprine in patients with pemphigus, study shows.

Nemolizumab Findings Positive for Younger Kids With AD

Already FDA-approved for adults and children 12 years or older, researchers explore extending the nemolizumab age range down to 2 years in atopic dermatitis.

Systemic Onychomycosis Rxs: Hepatoxicity Risks Compared

Terbinafine shows lower risk for hepatotoxicity than other systemic antifungal treatments in patients with onychomycosis and chronic liver disease.

Replimune's Drug for Advanced Skin Cancer Fails to Win FDA Nod Again

The U.S. Food and Drug Administration on Friday declined to approve Replimune's drug ⁠for advanced skin cancer, citing insufficient data from studies, sending its shares...

Most US Infants Have an Enteric Viral Infection by Age 2

Norovirus GII and sapovirus were the most common pathogens and would be targets for vaccines.

Conference MDAngle: AAN 2026 Myasthenia Gravis

Insights from AAN 2026, including anticipated presentations, key takeaways, and how emerging research in myasthenia gravis may affect patient care.

Potato Allergy in Children: New Data

Potato allergies tend to appear in infancy, often with skin symptoms, and may be triggered by the vegetable when it is cooked or raw, according to a Turkish study.

‘Unchartered Territory’: CAR T Results in Ped Rheumatology

Among the challenges of conducting larger clinical trials is identifying appropriate patient populations.

Neuroimmunome Predicts Viral Hepatitis Severity

A neuroimmune gene signature detectable in blood and liver predicts viral hepatitis severity, suggesting nervous-immune crosstalk drives disease progression and informs monitoring.

Consider Kids’ Sports Gear as a Source of Contact Dermatitis

Modifications and alternative products can help manage sports-related allergens in children with allergic contact dermatitis.

Recommended News For You

Improved end-of-life conversations for cancer patients are identified by a new study.

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

Study identifies new target for obesity-related breast cancer

Study reveals increase in late-stage breast cancer diagnoses in US

What does it mean for Biden's prostate cancer to be 'aggressive'? A urologic surgeon explains

How cancer misinformation exploits the way we think

A Chemo-Free Option for Some Advanced Endometrial Cancers?

Recommended Articles For You

Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia 

Navigating the Unknown: How to Cope with Anaplastic Thyroid Cancer 

Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer 

Vaccines that can help prevent cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study reveals increase in late-stage breast cancer diagnoses in US

2.

La FDA ha approvato Talzenna per trattare il cancro alla prostata metastatico che non è resistente alla castrazione.

3.

Alone for 500 Days, but Never Lonely: The Introvert's Dream.

4.

Cancer research in the US is world class. With the government pulling out, its future is uncertain

5.

An individual state lost $4.02 billion due to untreated mental illness.

1.

The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis

2.

The Importance of Balanced Potassium Levels in Maintaining Good Health

3.

Seeing the Difference: Using Ultrasound to Distinguish Fibroadenoma from Cancer

4.

Exploring the Latest Treatments for Essential Thrombocythemia

5.

Predicting Incidental Prostate Cancer in BPH Surgery Patients

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Current Scenario of Cancer- Q&A Session to Close the Gap

2.

Should We Use DARA Up Front As First-Line Therapy in MM? - Part II

3.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III

5.

Current Scenario of Cancer- Palliative Care to Close the Care Gap

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot